Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-... Read more
Cytodyn
Vancouver, United States · Post IPO Equity
Ultivue
Cambridge, United States · Series D
Adaptive Phage Therapeutics
Gaithersburg, United States · Grant
Regeneron
Tarrytown, United States · Post IPO Equity
Be Bio
Cambridge, United States · Series B
Verve Therapeutics
Cambridge, United States · IPO
Biogen
Cambridge, United States
Century Therapeutics
Philadelphia, United States · Post IPO Equity
Guardant Health
Redwood City, United States · Venture
Genentech
South San Francisco, United States · Venture
Natera
Austin, United States · Post IPO Equity
Biomason
Durham, United States · Series C